All News

April 23, 2019

Transplant centers, patients unite to stop new organ sharing policy that threatens longer waits for a liver

Vanderbilt University Medical Center and 13 other highly regarded liver transplant centers have filed a lawsuit aimed at stopping Federal policy changes that are slated to take effect Tuesday, April 30, that will affect thousands of patients across the Southeast and Midwest waiting for donor livers.

From left, Benjamin Brown, Christine Lovly, MD, PhD, Yun-Kai Zhang, PhD, Jens Meiler, PhD, and colleagues are exploring new ways to understand resistance to targeted cancer therapy drugs.
April 11, 2019

Study reframes approach to targeted therapy resistance

When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.

March 25, 2019

Ten years ago, Mike Lavin was saved by a bone marrow transplant. A few days ago, he paid a surprise visit to the donor who made it possible.

“I really appreciate everything you have done. I’m here because of you.”

Marissa Kirkendall, Certified Child Life Specialist, presents patient Raelynn Settles, 2, with a Joy in Childhood Foundation custom Starlight Gown featuring fun and colorful artwork.
March 21, 2019

Children’s Hospital surgery waiting area receives redesign

Children and families anticipating surgery or other procedures at Monroe Carell Jr. Children’s Hospital at Vanderbilt now have a newly renovated area designed with therapeutic and diversionary activities to engage them as they wait.

March 4, 2019

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

February 28, 2019

Investigators map genomic landscape of very rare cancer

A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.